Αποτελέσματα Αναζήτησης
18 Αυγ 2023 · WHO develops most up-to-date technical guidance for clinical management of COVID-19 patients, including optimized supportive care interventions and therapeutics based on ongoing “living” assessment of new evidence generated by the global community.
The FDA granted EUA to nirmatrelvir/ritonavir on December 22, 2021 for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (≥12 years of age and weighing ≥40 kg) who are at high risk for progression to severe COVID-19, including hospitalization or death [235].
14 Οκτ 2024 · In summary, WATCH integrates a mobile post-COVID-19 outpatient clinic with multimodal holistic telemedicine interventions to provide high-quality therapy, particularly for patients with post-COVID-19 condition in rural regions.
27 Νοε 2020 · There are two approaches concerning medicinal therapy for severely affected hospitalized COVID-19 patients: antiviral treatment and modulation of the immune response. In the following, we summarize data on pharmacologic therapies published in at least one case series or cohort study.
18 Αυγ 2021 · Learn about serious symptoms of the novel coronavirus disease, the types of supportive medical treatments hospitals provide, including mechanical ventilation, and what's known about medications for COVID-19.
As COVID-19 continues to affect people around the world, researchers are racing to develop effective treatments to help save lives, improve the health outcomes for patients and lessen the burden on health systems.
4 Ιουλ 2020 · So the first treatment for people hospitalized with COVID-19 is oxygen, typically delivered through a mask or nasal prongs. Most patients also get remdesivir, the lone COVID-19 treatment that's been formally approved by FDA.
